 | • レポートコード：MRC2205A022 • 出版社/出版日：Transparency Market Research / 2022年3月17日 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、世界の予防医療技術＆サービス市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、早期発見＆スクリーニング技術別（個別化医療、自動スクリーニング、その他高度スクリーニング検査）分析、予防技術別分析、高度過誤低減技術別分析、慢性疾患管理技術別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の予防医療技術＆サービス市場規模：早期発見＆スクリーニング技術別（個別化医療、自動スクリーニング、その他高度スクリーニング検査） ・世界の予防医療技術＆サービス市場規模：予防技術別 ・世界の予防医療技術＆サービス市場規模：高度過誤低減技術別 ・世界の予防医療技術＆サービス市場規模：慢性疾患管理技術別 ・世界の予防医療技術＆サービス市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Preventive Healthcare Technologies and Services Market – Scope of Report
TMR’s report on the global preventive healthcare technologies and services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global preventive healthcare technologies and services market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global preventive healthcare technologies and services market from 2021 to 2028.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the preventive healthcare technologies and services market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global preventive healthcare technologies and services market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global preventive healthcare technologies and services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global preventive healthcare technologies and services market.
The report delves into the competitive landscape of the global preventive healthcare technologies and services market. Key players operating in the global preventive healthcare technologies and services market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global preventive healthcare technologies and services market profiled in this report.
Key Questions Answered in Preventive Healthcare Technologies and Services Market Report
What will be the revenue generated in the preventive healthcare technologies and services market across all regions during the forecast period?
What are key trends in the preventive healthcare technologies and services market?
What are major drivers, restraints, and opportunities in the market?
Which region is set to expand at the maximum CAGR during the forecast period?
Which segment of the preventive healthcare technologies and services will generate the maximum revenue globally by 2028?
Which device segment will expand at the maximum CAGR during the forecast period?
Preventive Healthcare Technologies and Services Market – Research Objectives and Research Approach
The comprehensive report on the global preventive healthcare technologies and services market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global preventive healthcare technologies and services market in terms of early detection & screening technologies, prophylaxis technologies, advanced technologies to reduce errors, and chronic disease management technologies. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global preventive healthcare technologies and services market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Preventive Healthcare Technologies and Services Market
4. Market Overview
4.1. Introduction
4.1.1. Early Detection & Screening Technologies Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Key Mergers & Acquisitions
5.3. Technological Advancements
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, By Early Detection & Screening Technologies
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028
6.3.1. Personalized Medicine
6.3.2. Automated Screening
6.3.3. Other advanced screening tests
6.4. Market Attractiveness Analysis, By Early Detection & Screening Technologies
7. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, By Prophylaxis Technologies
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028
7.3.1. Influenza Vaccines
7.3.2. Meningococcal Vaccines
7.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
7.3.4. Human Papilloma Virus Vaccine
7.3.5. Other new vaccines
7.4. Market Attractiveness Analysis, By Prophylaxis Technologies
8. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, By Advance Technologies to Reduce Errors
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028
8.3.1. Electronic Prescribing
8.3.2. Computerized Provider Order Entry Systems
8.3.3. Clinical Decision Support System
8.3.4. Automated Prescription, Formulation, and Dispensing
8.3.5. Smart Infusion Pumps
8.3.6. Smart Packaging
8.4. Market Attractiveness Analysis, By Advance Technologies to Reduce Errors
9. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, By Country/Region
10. North America Preventive Healthcare Technologies and Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017- 2028
10.2.1. Personalized Medicine
10.2.2. Automated Screening
10.2.3. Other Advanced Screening Tests
10.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028
10.3.1. Influenza Vaccines
10.3.2. Meningococcal Vaccines
10.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
10.3.4. Human Papilloma Virus Vaccine
10.3.5. Other new vaccines
10.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028
10.4.1. Electronic Prescribing
10.4.2. Computerized Provider Order Entry Systems
10.4.3. Clinical Decision Support System
10.4.4. Automated Prescription, Formulation, and Dispensing
10.4.5. Smart Infusion Pumps
10.4.6. Smart Packaging
10.5. Market Value Forecast, by Country, 2017–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Early Detection & Screening Technologies
10.6.2. By Prophylaxis Technologies
10.6.3. By Advance Technologies to Reduce Errors
10.6.4. By Country
11. Europe Preventive Healthcare Technologies and Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028
11.2.1. Personalized Medicine
11.2.2. Automated Screening
11.2.3. Other Advanced Screening Tests
11.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028
11.3.1. Influenza Vaccines
11.3.2. Meningococcal Vaccines
11.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
11.3.4. Human Papilloma Virus Vaccine
11.3.5. Other new vaccines
11.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028
11.4.1. Electronic Prescribing
11.4.2. Computerized Provider Order Entry Systems
11.4.3. Clinical Decision Support System
11.4.4. Automated Prescription, Formulation, and Dispensing
11.4.5. Smart Infusion Pumps
11.4.6. Smart Packaging
11.5. Market Value Forecast, by Country/Sub-region, 2017–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Early Detection & Screening Technologies
11.6.2. By Prophylaxis Technologies
11.6.3. By Advance Technologies to Reduce Errors
11.6.4. By Country/Sub-region
12. Asia Pacific Preventive Healthcare Technologies and Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028
12.2.1. Personalized Medicine
12.2.2. Automated Screening
12.2.3. Other Advanced Screening Tests
12.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028
12.3.1. Influenza Vaccines
12.3.2. Meningococcal Vaccines
12.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
12.3.4. Human Papilloma Virus Vaccine
12.3.5. Other new vaccines
12.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028
12.4.1. Electronic Prescribing
12.4.2. Computerized Provider Order Entry Systems
12.4.3. Clinical Decision Support System
12.4.4. Automated Prescription, Formulation, and Dispensing
12.4.5. Smart Infusion Pumps
12.4.6. Smart Packaging
12.5. Market Value Forecast, by Country/Sub-region, 2017–2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Early Detection & Screening Technologies
12.6.2. By Prophylaxis Technologies
12.6.3. By Advance Technologies to Reduce Errors
12.6.4. By Country/Sub-region
13. Latin America Preventive Healthcare Technologies and Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028
13.2.1. Personalized Medicine
13.2.2. Automated Screening
13.2.3. Other Advanced Screening Tests
13.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028
13.3.1. Influenza Vaccines
13.3.2. Meningococcal Vaccines
13.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
13.3.4. Human Papilloma Virus Vaccine
13.3.5. Other new vaccines
13.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028
13.4.1. Electronic Prescribing
13.4.2. Computerized Provider Order Entry Systems
13.4.3. Clinical Decision Support System
13.4.4. Automated Prescription, Formulation, and Dispensing
13.4.5. Smart Infusion Pumps
13.4.6. Smart Packaging
13.5. Market Value Forecast, by Country/Sub-region, 2017–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Early Detection & Screening Technologies
13.6.2. By Prophylaxis Technologies
13.6.3. By Advance Technologies to Reduce Errors
13.6.4. By Country/Sub-region
14. Middle East & Africa Preventive Healthcare Technologies and Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028
14.2.1. Personalized Medicine
14.2.2. Automated Screening
14.2.3. Other Advanced Screening Tests
14.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028
14.3.1. Influenza Vaccines
14.3.2. Meningococcal Vaccines
14.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines
14.3.4. Human Papilloma Virus Vaccine
14.3.5. Other new vaccines
14.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028
14.4.1. Electronic Prescribing
14.4.2. Computerized Provider Order Entry Systems
14.4.3. Clinical Decision Support System
14.4.4. Automated Prescription, Formulation, and Dispensing
14.4.5. Smart Infusion Pumps
14.4.6. Smart Packaging
14.5. Market Value Forecast, by Country/Sub-region, 2017–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Early Detection & Screening Technologies
14.6.2. By Prophylaxis Technologies
14.6.3. By Advance Technologies to Reduce Errors
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix
15.2. Market Share Analysis, by Company, 2020
15.3. Market Footprint Analysis
15.3.1. By Region
15.3.2. By Early Detection & Screening Technologies Type
15.4. Competitive Business Strategies
15.5. Company Profiles
15.5.1. Alere
15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.1.2. Product Portfolio
15.5.1.3. SWOT Analysis
15.5.1.4. Strategic Overview
15.5.2. Dilon Technologies, Inc.
15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.2.2. Product Portfolio
15.5.2.3. SWOT Analysis
15.5.2.4. Strategic Overview
15.5.3. GlaxoSmithKline plc
15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.3.2. Product Portfolio
15.5.3.3. SWOT Analysis
15.5.3.4. Strategic Overview
15.5.4. Healthways, Inc.
15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.4.2. Product Portfolio
15.5.4.3. SWOT Analysis
15.5.4.4. Strategic Overview
15.5.5. Lifecom, Inc.
15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.5.2. Product Portfolio
15.5.5.3. SWOT Analysis
15.5.5.4. Strategic Overview
15.5.6. Medtronic.
15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.6.2. Product Portfolio
15.5.6.3. SWOT Analysis
15.5.6.4. Strategic Overview
15.5.7. Merck & Co.
15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.7.2. Product Portfolio
15.5.7.3. SWOT Analysis
15.5.7.4. Strategic Overview
15.5.8. Myraid Genetics
15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.8.2. Product Portfolio
15.5.8.3. SWOT Analysis
15.5.8.4. Strategic Overview
15.5.9. Novx Systems, Inc.
15.5.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.9.2. Product Portfolio
15.5.9.3. SWOT Analysis
15.5.9.4. Strategic Overview
15.5.10. Omnicell, Inc.
15.5.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.10.2. Product Portfolio
15.5.10.3. SWOT Analysis
15.5.10.4. Strategic Overview
15.5.11. Omron Healthcare, Inc.
15.5.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.11.2. Product Portfolio
15.5.11.3. SWOT Analysis
15.5.11.4. Strategic Overview
15.5.12. Sanofi Pasteur MSD
15.5.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.12.2. Product Portfolio
15.5.12.3. SWOT Analysis
15.5.12.4. Strategic Overview
15.5.13. Scripto LLC
15.5.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.13.2. Product Portfolio
15.5.13.3. SWOT Analysis
15.5.13.4. Strategic Overview
15.5.14. U-Systems, Inc.
15.5.14.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.14.2. Product Portfolio
15.5.14.3. SWOT Analysis
15.5.14.4. Strategic Overview